linkedin
BROUGHT TO YOU BY
Exclusive Access, Inclusive Growth

WELCOME TO ET PRIME

BROUGTH TO YOU BY
Exclusive Access, Inclusive Growth
ET Prime
Pharma

Four brands made JB Chemicals a prize catch for KKR. Next, the PE firm needs to belt out new hits.

The pharma company has robust financials and a decent corporate-governance record, but the cherries on the cake are four big brands, which account for 80%-85% of the company’s domestic formulations business. The game changer for KKR will be to leverage its connections and create lucrative revenue streams beyond the big four.
font size
FONT SIZE
save
SAVE
saved
SAVED
Gift this article
GIFT ARTICLE
9 Jul 2020 8 Mins Read 1 comments
Getty Images
JB Chemicals and Pharmaceuticals, a relatively reserved drug maker, has come into the limelight, with global private-equity (PE) firm KKR set to acquire a 54% stake in the company at INR745 per share. This will trigger an open offer for another 26% stake, but KKR will cap its overall holding at 64.9%. Until a year ago, PE firms
will also help the company pursue strategic acquisition opportunities to add to its portfolio,” the spokesperson adds. While KKR has not elaborated on the strategy for JB Chemicals, it will be interesting to watch the tricks it has up its sleeve to achieve the goals. ( Research support by Rochelle Britto; g raphics by Sadhana Saxena)
JB Chemicals and Pharmaceuticals, a relatively reserved drug maker, has come into the limelight, with global private-equity (PE) firm KKR set to acquire a 54% stake in the company at INR745 per share. This will trigger an open offer for another 26% stake, but KKR will cap its overall holding at 64.9%. Until a year ago, PE firms will also help the company pursue strategic acquisition opportunities to add to its portfolio,” the spokesperson adds. While KKR has not elaborated on the strategy for JB Chemicals, it will be interesting to watch the tricks it has up its sleeve to achieve the goals. ( Research support by Rochelle Britto; g raphics by Sadhana Saxena)

The latest from ET Prime is now on Telegram. To subscribe to our Telegram newsletter click here.

Gift this story

YOU CAN GIFT 0 MORE STORIES THIS MONTH

Maximum 10 Email IDs allowed

300 characters remaining

Gift Sent Successfully

Limit Reached
Limit Reached

You’ve gifted all the 0 articles from your monthly gift bucket!

Please come back next month.

0 more articles will be waiting for you in your gift bucket.

CONTRIBUTORS WHO HAVE COMMENTED ON THIS STORY

test

user Isha Trivedi ET Prime, Assistant Editor - Pharma, Healthcare

Current Edition

[[^message]]

Result

[[/message]] [[#message]]

[[message]]

[[/message]]